Abstract
We recently finemapped a type 1 diabetes (T1D)-linked region on chromosome 21, indicating that one or more T1D-linked genes exist in this region with 33 annotated genes. In the current study, we have taken a novel approach using transcriptional profiling in predicting and prioritizing the most likely candidate genes influencing beta-cell function in this region. Two array-based approaches were used, a rat insulinoma cell line (INS-1αβ) overexpressing pancreatic duodenum homeobox 1 (pdx-1) and treated with interleukin 1β (IL-1β) as well as human pancreatic islets stimulated with a mixture of cytokines. Several candidate genes with likely functional significance in T1D were identified. Genes showing differential expression in the two approaches were highly similar, supporting the role of these specific gene products in cytokine-induced beta-cell damage. These were genes involved in cytokine signaling, oxidative phosphorylation, defense responses and apoptosis. The analyses, furthermore, revealed several transcription factor binding sites shared by the differentially expressed genes and by genes demonstrating highly similar expression profiles with these genes. Comparable findings in the rat beta-cell line and human islets support the validity of the methods used and support this as a valuable approach for gene mapping and identification of genes with potential functional significance in T1D, within a region of linkage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nerup J, Pociot F, Holm P, Julier C, Kochum I, Senee V et al. A genomewide scan for Type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301–1313.
Bergholdt R, Nerup J, Pociot F . Fine mapping of a region on chromosome 21q21.11–q22.3 showing linkage to type 1 diabetes. J Med Genet 2005; 42: 17–25.
Cheung V, Conlin L, Weber T, Arcaro M, Jen K, Morley M et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33: 422–425.
Morley M, Molony C, Weber T, Devlin J, Ewens K, Spielman R et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743–747.
Wang H, Maechler P, Ritz-Laser B, Hagenfeldt K, Ishihara H, Philippe J et al. Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. J Biol Chem 2001; 276: 25279–25286.
Nielsen K, Kruhoffer M, Orntoft T, Sparre T, Wang H, Wollheim C et al. Gene expression profiles during beta cell maturation and after IL-1 beta exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1 beta sensitivity. Diabetologia 2004; 47: 2185–2199.
Nielsen K, Karlsen AE, Deckert M, Madsen OD, Serup P, Mandrup-Poulsen T et al. Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 1999; 48: 2324–2332.
Mandrup-Poulsen T, Helqvist S, Molvig J, Wogensen L, Nerup J . Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989; 4: 191–218.
Jonsson PF, Cavanna T, Zicha D, Bates PA . Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis. BMC Bioinformatics 2006; 7: 2.
McInnes IB, Gracie JA . Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004; 4: 392–397.
Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL . IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 2003; 46: 255–266.
Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervongsky AV . Contribution of fas to diabetes development. Proc Natl Acad Sci USA 2003; 100: 628–632.
Vence L, Benoist C, Mathis D . Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells. Diabetes 2004; 53: 2797–2803.
Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB . Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 1998; 101: 1811–1820.
Martin S, van den Engel NK, Vinke A, Heidenthal E, Schulte B, Kolb H . Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J Autoimmun 2001; 17: 109–117.
Camacho SA, Heath WR, Carbone FR, Sarvetnick N, LeBon A, Karlsson L et al. A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 2001; 2: 523–529.
Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI et al. On the pathogenesis of IDDM. Diabetologia 1994; 37: S82–S89.
Sparre T, Christensen UB, Larsen PM, Fey SJ, Wrzesinski K, Roepstorff P et al. IL-1 beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002; 45: 1550–1561.
Eizirik DL, Pavlovic D . Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM? Diabetes Metab Rev 1997; 13: 293–307.
Bergholdt R, Eising S, Nerup J, Pociot F . Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia 2006; 49: 1179–1182.
Wu Z, Irizarry R, Gentleman R, Murillo F, Spencer F . A model-based background adjustment for oligonucleotide expression arrays. Technical report, John Hopkins University, Department of Biostatistics Working Papers. Baltimore, MD, USA, 2003.
Smyth GK . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article 3. http://www.bepress.com/sagmb/vol3/iss1/art3.
Benjamini Y, Hochberg Y . Controlling the false discovery rate – a practical and powerful approach to multiple testing. J Roy Sta B 1995; 57: 289–300.
Allison DB, Cui X, Page GP, Sabripour M . Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55–65.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408.
Aerts S, Van-Loo P, Thijs G, Mayer H, de-Martin R, Moreau Y et al. TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 2005; 33: W393–W396.
Acknowledgements
We thank Susanne Munch and Bodil Bosmann Jørgensen for excellent technical expertise. Support from the Foundation of 17-12-1981, the Sehested-Hansen Foundation, the Danish Diabetes Association, the AP Moller Foundation for the Advancement of Medical Science, the European Foundation for the Study of Diabetes (Type 1 Diabetes Research Grant), the Juvenile Diabetes Research Foundation (RFA DK-99-002) as well as the Danish Medical Research Council is greatly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)
Supplementary information
Rights and permissions
About this article
Cite this article
Bergholdt, R., Karlsen, A., Hagedorn, P. et al. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets. Genes Immun 8, 232–238 (2007). https://doi.org/10.1038/sj.gene.6364379
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364379